DARE · Dare Bioscience, Inc.
$0.93
-0.44 (-32.12%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on our current analysis of the conditions described above, there is substantial doubt about our ability to continue as a going concern within the 12-month period from the issuance date of the accompanying condensed consolidated financial statements.”View the 10-Q filed Aug 13, 2026
Market Cap
$14.22M
Shares
15.29M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 24,069 | 208,941 | 233,010 | 50.4% |
| 2026-06-29 | 62,847 | 216,820 | 279,667 | 55.2% |
| 2026-06-22 | 53,672 | 400,707 | 454,379 | 57.2% |
| 2026-06-15 | 61,412 | 304,334 | 365,746 | 40.6% |
| 2026-06-08 | 45,635 | 353,283 | 398,918 | 59.3% |
| 2026-06-01 | 62,481 | 564,016 | 626,497 | 56.4% |
| 2026-05-25 | 51,312 | 494,046 | 545,358 | 57.5% |
| 2026-05-18 | 132,833 | 1,019,078 | 1,151,911 | 58.5% |
| 2026-05-11 | 185,440 | 2,201,249 | 2,386,689 | 51.8% |
| 2026-05-04 | 361,857 | 4,890,343 | 5,252,200 | 57.2% |
| 2026-04-27 | 68,359 | 743,908 | 812,267 | 58.4% |
| 2026-04-20 | 109,103 | 1,962,284 | 2,071,387 | 56.4% |
| 2026-04-13 | 431,024 | 6,745,927 | 7,176,951 | 54.3% |
| 2026-04-06 | 37,767 | 160,542 | 198,309 | 56.3% |
| 2026-03-30 | 45,266 | 386,305 | 431,571 | 60.0% |
| 2026-03-23 | 37,914 | 323,570 | 361,484 | 57.7% |
| 2026-03-16 | 20,512 | 260,775 | 281,287 | 56.5% |
| 2026-03-09 | 18,020 | 105,307 | 123,327 | 50.2% |
| 2026-03-02 | 25,272 | 161,242 | 186,514 | 53.4% |
| 2026-02-23 | 34,665 | 335,331 | 369,996 | 58.9% |
| 2026-02-16 | 11,867 | 78,936 | 90,803 | 48.4% |
| 2026-02-09 | 13,574 | 114,446 | 128,020 | 61.5% |
| 2026-02-02 | 9,778 | 262,463 | 272,241 | 59.2% |
| 2026-01-26 | 13,944 | 219,300 | 233,244 | 54.9% |
| 2026-01-19 | 25,079 | 137,186 | 162,265 | 51.6% |
| 2026-01-12 | 15,543 | 170,289 | 185,832 | 63.3% |
| 2026-01-05 | 14,911 | 163,826 | 178,737 | 52.5% |
| 2025-12-29 | 19,070 | 402,786 | 421,856 | 65.9% |
| 2025-12-22 | 20,811 | 225,193 | 246,004 | 58.0% |
| 2025-12-15 | 107,959 | 915,411 | 1,023,370 | 58.5% |
| 2025-12-08 | 138,269 | 1,683,737 | 1,822,006 | 54.2% |
| 2025-12-01 | 36,022 | 223,343 | 259,365 | 56.6% |
| 2025-11-24 | 16,350 | 83,395 | 99,745 | 54.2% |
| 2025-11-17 | 30,795 | 344,597 | 375,392 | 59.1% |
| 2025-11-10 | 26,744 | 245,356 | 272,100 | 62.6% |
| 2025-11-03 | 20,366 | 292,452 | 312,818 | 54.8% |
| 2025-10-27 | 20,672 | 304,299 | 324,971 | 62.5% |
| 2025-10-20 | 53,540 | 423,626 | 477,166 | 71.2% |
| 2025-10-13 | 67,041 | 1,378,477 | 1,445,518 | 78.3% |
| 2025-10-06 | 37,592 | 665,026 | 702,618 | 72.3% |
| 2025-09-29 | 18,442 | 318,122 | 336,564 | 71.1% |
| 2025-09-22 | 26,335 | 354,875 | 381,210 | 57.6% |
| 2025-09-15 | 21,717 | 306,232 | 327,949 | 55.0% |
| 2025-09-08 | 26,730 | 331,945 | 358,675 | 62.7% |
| 2025-09-01 | 12,590 | 298,895 | 311,485 | 61.5% |
| 2025-08-25 | 15,870 | 313,501 | 329,371 | 51.7% |
| 2025-08-18 | 68,894 | 407,493 | 476,387 | 65.5% |
Showing 1–47 of 47 weeks
Key facts
CIK
1401914
CUSIP
23666P200
13F (30d)
28 filings
28 filers
Visit website
Investor relations